Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc (LSE/NYSE: HLN) covers the month of June 2025, with a report date of June 17, 2025. The filing serves as a notification and public disclosure under the UK Market Abuse Regulation regarding a transaction by a Person Discharging Managerial Responsibilities (PDMR). Haleon operates as a global leader in consumer health with a portfolio spanning Oral Health, Vitamins, Minerals and Supplements, Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics. This document is a regulatory disclosure of a specific share transaction rather than a financial performance report.
Material Changes and Transaction Details
The filing discloses the following transaction details:
- Person: Marie-Anne Aymerich, Independent Non-Executive Director (PDMR).
- Transaction Type: Acquisition of Ordinary Shares via dividend reinvestment.
- Date of Transaction: June 12, 2025.
- Place of Transaction: London Stock Exchange (XLON).
- Instrument: Ordinary Shares of £0.01 each (ISIN: GB00BMX86B70).
- Volume: 320 shares.
- Price: £4.07 per share.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary on financial performance, risks, contingencies, or unusual items. The document is limited to the statutory disclosure of the PDMR shareholding change.
Key Facts for Investor Verification
- Verify the current share price of Haleon Plc on the London Stock Exchange to contextualize the £4.07 transaction price.
- Confirm the total shareholding of Marie-Anne Aymerich post-transaction to assess her total exposure.
- Review the company's most recent Form 20-F or quarterly earnings release for actual financial performance metrics, as this 6-K does not contain them.
- Check for any other PDMR transactions reported around the same period to identify broader insider trading trends.